Clinical Trial Update: Study in Women With Metastatic Breast Cancer Whose Cancer Has Gotten Worse After Anthracycline and Taxane Therapy [Phase 2]

View source ↗

Summary

Pfizer-sponsored Phase 2 clinical trial in women with metastatic breast cancer that progressed after anthracycline and taxane therapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Pfizer | Conditions: Breast Neoplasms, Neoplasm Metastasis | Phase 2 | Status: COMPLETED